PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
11-Oct-2023 Lucy Therapeutics Expands Cutting-Edge Medical Research Program Businesswire
11-Oct-2023 Charles River Laboratories Achieves 90% Renewable Electricity Globally, Announces Progress on Environmental Goals Businesswire
11-Oct-2023 Global Antibiotic Resistance Markets, 2023-2027: Therapeutics, Pathogen, Therapy Type - Unveiling the Future of AMR with Phages, Supercomputers, and Nanoparticles - ResearchAndMarkets.com Businesswire
11-Oct-2023 Health Canada Approves Eurofins CDMO Alphora Inc.’s Cannabis Drug License for Synthetic Phytocannabinoids Businesswire
11-Oct-2023 Unlocking Opportunities in the Bioanalytical Testing Services Market: Insights, Trends, and Future Projections - ResearchAndMarkets.com Businesswire
11-Oct-2023 IQVIA and CEPI Collaborate to Strengthen Global Research Preparedness to Advance the 100 Days Mission Businesswire
11-Oct-2023 Meet the UK’s largest scientific instrumentation distributor at Lab Innovations SciMed
11-Oct-2023 Anton Paar to exhibit at Lab Innovations 2023 Anton Paar
11-Oct-2023 Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023 Businesswire
11-Oct-2023 Chethan Visweswar Joins the Movius Executive Team Businesswire
11-Oct-2023 Global Adult Vaccines Market Research Report 2023: Market to Surpass $25 Billion by 2027 - Long-term Forecasts to 2032 - ResearchAndMarkets.com Businesswire
11-Oct-2023 AM-Pharma Announces Positive Clinical Data From Phase 1b Study Evaluating Ilofotase Alfa in Hypophosphatasia Patients Businesswire
11-Oct-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
11-Oct-2023 Bristol Myers Squibb Presents New Zeposia (ozanimod) Data on Long-Term Disease Progression and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Businesswire
11-Oct-2023 First-Ever Clinical Trial Exclusively in Black and Hispanic / Latinx People Living With Multiple Sclerosis Shows Genentech’s Ocrevus Effectively Manages Disease Activity Businesswire
11-Oct-2023 Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete Suppression of Brain Lesions Businesswire
11-Oct-2023 TheraVet: BIOCERA-VET in Horse Bone Cysts Highlighted at an International Equine Conference in the USA Businesswire
11-Oct-2023 Gritgen Therapeutics Launches Commercial GMP Facility in Suzhou, China Businesswire
10-Oct-2023 Nymox risponde alla Corte Suprema delle Bahamas che si pronuncia a favore del Comitato per il ripristino del valore degli azionisti di Nymox: emette l'ingiunzione di congelare le azioni del CEO di Averback e ordina l'assemblea degli azionisti. Businesswire
10-Oct-2023 Nymox reageert nu het hooggerechtshof van de Bahama's uitspraak doet ten gunste van de CRNSV (Committee to Restore Nymox Shareholder Value): het Hof vaardigt een bevel uit om de aandelen van CEO Averback... Businesswire